Literature DB >> 1643888

Plasma endothelin levels are increased during septic shock.

H J Voerman1, C D Stehouwer, G J van Kamp, R J Strack van Schijndel, A B Groeneveld, L G Thijs.   

Abstract

OBJECTIVE: To study whether serially measured plasma concentrations of endothelin (a novel, potent, endogenous vasoconstrictor derived from endothelium and macrophages) relate to the pathophysiology and severity of human septic shock.
DESIGN: Prospective analysis.
SETTING: Medical ICU of a university hospital. PATIENTS: Six patients with septic shock, studied for 8 days after ICU admission.
MEASUREMENTS AND MAIN RESULTS: The initial plasma endothelin concentration was increased (14.2 +/- 5.2 [SD] vs. normal 4.2 +/- 0.7 pg/mL, p less than .05) and correlated with the Acute Physiology and Chronic Health Evaluation II score (r2 = .79, p less than .05). For pooled data, endothelin levels correlated poorly with leukocyte counts (r2 = .13), mean arterial pressure (MAP) (r2 = .16), and administered doses of dopamine (r2 = .26). In multiple regression analyses, plasma endothelin concentrations were predicted by dopamine doses and not by MAP. Plasma endothelin concentrations predicted the decrease in creatinine clearance, independently from MAP. The pooled value for correlations between endothelin levels and creatinine clearance, during the course of disease in individual patients, was statistically significant (r2 = .31).
CONCLUSIONS: During septic shock, the release or production of endothelin may increase as a consequence of endothelial injury by activated leukocytes and the infusion of catecholamines, and this mechanism may relate to renal vasoconstriction and to the severity of disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643888     DOI: 10.1097/00003246-199208000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.

Authors:  T Hohlfeld; P Klemm; C Thiemermann; T D Warner; K Schrör; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system.

Authors:  K E Wiley; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 4.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

5.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

6.  Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Werner Zimmerli; Beat Mueller
Journal:  Intensive Care Med       Date:  2011-03-11       Impact factor: 17.440

7.  Establishment of permanent human endothelial cells achieved by transfection with SV40 large T antigen that retain typical phenotypical and functional characteristics.

Authors:  F Moldovan; H Benanni; J Fiet; O Cussenot; J Dumas; C Darbord; H R Soliman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-01       Impact factor: 2.416

Review 8.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

9.  Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

Authors:  J Boldt; T Menges; D Kuhn; C Diridis; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

Review 10.  Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease.

Authors:  G Noll; R R Wenzel; T F Lüscher
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.